A detailed history of Krilogy Financial LLC transactions in Repligen Corp stock. As of the latest transaction made, Krilogy Financial LLC holds 13,662 shares of RGEN stock, worth $2.08 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
13,662
Previous 20,201 32.37%
Holding current value
$2.08 Million
Previous $2.51 Million 27.31%
% of portfolio
0.08%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$111.43 - $134.0 $728,640 - $876,226
-6,539 Reduced 32.37%
13,662 $1.83 Million
Q2 2025

Jul 09, 2025

BUY
$108.89 - $145.23 $2.2 Million - $2.93 Million
20,201 New
20,201 $2.51 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.46B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.